30Mar 2016

Chitin and Chitosan: Production and Application of Versatile Biomedical Nanomaterials.

  • Tabriz Medical University, East Azerbaijan, Tabriz, Iran.
  • Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA.
  • Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, USA.
  • Abstract
  • Keywords
  • Cite This Article as
  • Corresponding Author

Chitin is the most abundant aminopolysaccharide polymer occurring in nature, and is the building material that gives strength to the exoskeletons of crustaceans, insects, and the cell walls of fungi. Through enzymatic or chemical deacetylation, chitin can be converted to its most well-known derivative, chitosan. The main natural sources of chitin are shrimp and crab shells, which are an abundant byproduct of the food-processing industry, that provides large quantities of this biopolymer to be used in biomedical applications. In living chitin-synthesizing organisms, the synthesis and degradation of chitin require strict enzymatic control to maintain homeostasis. Chitin synthase, the pivotal enzyme in the chitin synthesis pathway, uses UDP-N-acetylglucosamine (UDPGlcNAc), produce the chitin polymer, whereas, chitinase enzymes degrade chitin. Bacteria are considered as the major mediators of chitin degradation in nature. Chitin and chitosan, owing to their unique biochemical properties such as biocompatibility, biodegradability, non-toxicity, ability to form films, etc, have found many promising biomedical applications. Nanotechnology has also increasingly applied chitin and chitosan-based materials in its most recent achievements. Chitin and chitosan have been widely employed to fabricate polymer scaffolds. Moreover, the use of chitosan to produce designed-nanocarriers and to enable microencapsulation techniques is under increasing investigation for the delivery of drugs, biologics and vaccines. Each application is likely to require uniquely designed chitosan-based nano/micro-particles with specific dimensions and cargo-release characteristics. The ability to reproducibly manufacture chitosan nano/microparticles that can encapsulate protein cargos with high loading efficiencies remains a challenge. Chitosan can be successfully used in solution, as hydrogels and/or nano/microparticles, and (with different degrees of deacetylation) an endless array of derivatives with customized biochemical properties can be prepared. As a result, chitosan is one of the most well-studied biomaterials. The purpose of this review is to survey the biosynthesis and isolation, and summarize nanotechnology applications of chitin and chitosan ranging from tissue engineering, wound dressings, antimicrobial agents, antiaging cosmetics, and vaccine adjuvants.


[Daniel Elieh-Ali-Komi and Michael R Hamblin. (2016); Chitin and Chitosan: Production and Application of Versatile Biomedical Nanomaterials. Int. J. of Adv. Res. 4 (Mar). 411-427] (ISSN 2320-5407). www.journalijar.com


Michael R Hamblin